Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in-licensing, out-licensing, marketing and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Headquartered in Montreal, Knight operates in Canada and 11 countries across Latin America with around 1,000 employees globally, and its shares trade on the TSX under the symbol GUD.
Aucun commentaire disponible.
Laissez votre note & commentaire